Dr. Libutti is the Director of the Montefiore-Einstein Center for Cancer Care, Professor and Vice-Chairman of the Department of Surgery and Professor in the Department of Genetics at the Albert Einstein College of Medicine and the Montefiore Medical Center. He graduated from Harvard College and received his M.D. from the College of Physicians and Surgeons of Columbia University. Following his residency in Surgery, he completed a fellowship in Surgical Oncology and Endocrine Surgery at the National Cancer Institute (NCI) and was ultimately a tenured Senior Investigator and Chief of the Tumor Angiogenesis Section in the Surgery Branch, NCI. Dr. Libutti’s laboratory has focused on studies of the pathogenesis of neuroendocrine tumors and on the familial cancer syndromes MEN1 and vHL. His group developed some of the first mouse models of these conditions. Work from his laboratory has resulted in the development of gene expression signatures that are useful in distinguishing benign from malignant thyroid lesions. Dr. Libutti has received funding from both the intramural and extramural programs of the NCI since 1996. He has published over 250 peer reviewed journal articles and holds seven U.S. patents. He is the recipient of both NCI and NIH Director’s Awards. Dr. Libutti’s clinical interests are in endocrine and neuroendocrine tumors involving the thyroid, parathyroid, adrenal glands and pancreas. He is also a leader in regional cancer therapy and tumor targeted gene therapy and is the Editor-in- Chief of the Nature Journal Cancer Gene Therapy.